Two decades of FFAR4 biology: From nutrient sensing to therapeutic targeting
Open Access
- 20 November 2025
- journal article
- review article
- Published by Elsevier in Cell Reports
- Vol. 44 (11) , 116586
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK108773)
- National Institutes of Health
- National Natural Science Foundation of China (3247090211)
This publication has 176 references indexed in Scilit:
- Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular RiskJAMA Cardiology, 2021
- Hepatic Fibroblast Growth Factor 21 Is Involved in Mediating Functions of Liraglutide in Mice With Dietary ChallengeHepatology, 2021
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular RiskJAMA, 2020
- Effects of long-term vitamin D and n-3 fatty acid supplementation on inflammatory and cardiac biomarkers in patients with type 2 diabetes: secondary analyses from a randomised controlled trialDiabetologia, 2020
- Effect of Supplementation With Marine ω-3 Fatty Acid on Risk of Colorectal Adenomas and Serrated Polyps in the US General PopulationJAMA Oncology, 2020
- Icosabutate Exerts Beneficial Effects Upon Insulin Sensitivity, Hepatic Inflammation, Lipotoxicity, and Fibrosis in MiceHepatology Communications, 2019
- Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 DiabetesJAMA, 2019
- Fish oil and flax seed oil supplemented diets increase FFAR4 expression in the rat colonInflammation Research, 2015
- Docosahexaenoic acid selectively induces human prostate cancer cell sensitivity to oxidative stress through modulation of NF‐κBThe Prostate, 2011
- Effects of Omega-3 Fatty Acids on Cancer RiskJAMA, 2006